Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine in Thalassemia Major
NCT04260516Phase 1Completed
- Sponsor
- Beni Suef University
- Start
- Jun 2019
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of acetylcysteine in beta thalassemia major, sponsored by Beni Suef University. Primary endpoint: Oxidative stress index at 3 months. Started Jun 2019; status: completed.
02
Drugs
acetylcysteine
03
Conditions
beta thalassemia major
Beyond the preview
Go deeper on NCT04260516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04260516.